Loading Events
Advances in Health & Medicine Life Sciences Science and Innovation Management

Falling Walls Circle Table: Innovation in Biotech in Europe and Germany

Falling Walls Foundation | Stefan Oelrich, Gottfried Ludewig, Amir Nashat

LIVE: Setting the Post-Corona-Agenda

Falling Walls Circle Tables will give the spotlight to world-leading scientists, science strategists and policy-makers from academia, business and politics discuss how we can apply science, research and innovation to get the world moving again.

More information coming soon.

DIGITAL BROADCAST AND FREE FOR EVERYONE

This is a digital event. Shortly before the event starts, the stream will be made available on this site. Add the event to your schedule and receive a reminder.

Return to overview

Stefan Oelrich

Bayer AG

Stefan Oelrich is a member of the Board of Management of Bayer AG and President of its Pharmaceuticals Division, a position he has held since November 2018. Prior to joining the company, he was on the Executive Committee of Sanofi, leading its global Diabetes & Cardiovascular business. During his seven-year tenure, he was also at the helm of Sanofi Germany, Switzerland and Austria, as well as the Diabetes and Cardiovascular business unit in Europe. From 1989 to 2011, Mr. Oelrich held various leadership positions in the health care business of Bayer AG with extensive international experience spanning Latin America (Argentina, Uruguay), Europe (France, Belgium) and the United States. Mr. Oelrich is a member of the Supervisory Board of the university hospital Charité, member of the Supervisory Board of the Berlin Institute of Health and member of the Board of the American Chamber of Commerce in Germany.

Gottfried Ludewig

German Federal Ministery of Health

Head of Department “Digitization and Innovation”

Since April 2018, Dr. Gottfried Ludewig has been Head of the newly founded Department “Digitization and Innovation” at the German Federal Ministry of Health. In this role, he is responsible for legislative proposals such as the Digital Supply Act and the Patient Data Protection Act. These legislations initiated, among other things, electronic patient files, electronic law, the right of insured persons to be supplied with digital health applications (“apps on prescription”), and a comprehensive research data center. He also introduced the COVID warning app. Before that, he was a member of the Berlin House of Representatives for six years, where he acted as spokesman for health policies and as Deputy Chairman of the CDU parliamentary group. In addition to his parliamentary mandate, he worked part-time for PwC.

Amir Nashat

Dewpoint Therapeutics

Amir is a managing partner in Polaris’ Boston office. He joined Polaris in 2002 and focuses on investments in healthcare.

Amir currently represents Polaris as a Director of AgBiome, CAMP4 Therapeutics, Dewpoint Therapeutics, Freenome, Metacrine Therapeutics, Morphic Therapeutic (NASDAQ: MORF), Scholar Rock (NASDAQ: SRRK), and Syros Pharmaceuticals (NASDAQ: SYRS).

Additionally, Amir has served as a director of Adnexus Therapeutics (Bristol Myers Squibb), Athenix Corporation (Bayer), Avila Therapeutics (Celgene), Fate Therapeutics (NASDAQ: FATE), Living Proof (Unilever), Promedior Pharmaceuticals, Receptos (Celgene), Selecta Biosciences (NASDAQ: SELB), Sun Catalytix (Lockheed Martin), and TARIS Biomedical (J&J).

In addition to his investment role, Amir has served as the CEO of Dewpoint, Jnana, Living Proof, Olivo Labs, and Sun Catalytix. Amir also serves on the Partners Innovation Fund and the Investment Advisory Committee for The Engine at MIT, and helped launch the MIT Sandbox Innovation Fund as its active president.

He has been named to the Forbes Midas List of “Top 100 Venture Capitalists.”

Prior to joining Polaris, Amir completed his ScD as a Hertz Fellow in Chemical Engineering at the Massachusetts Institute of Technology with a minor in Biology under the guidance of Dr. Robert Langer. Amir also earned both his MS and BS in Materials Science and Mechanical Engineering at the University of California, Berkeley.

See all speakers
Next events
Life Sciences Digital Education Advances in Health & Medicine

Organoide des menschlichen Gehirns alias “Mini-Gehirne” als Werkzeuge zur Erforschung von Krankheiten des Nervensystems (DE)

Max-Delbrück-Centrum für Molekulare Medizin | Agnieszka Rybak-Wolf, Anna Löwa, Miriam Wandres, Luiza Bengtsson

Bitte melden Sie sich für diese Veranstaltung direkt beim Organisator an. Klicken Sie "Weiterlesen" für weitere Informationen.

Read more

More Events

All Events

We use cookies and other technologies to collect data about your use of our site and about your browser, device and location. We process this data to help us understand how the site is used and to personalize our content and the advertising you see on this and other sites we also share this data with advertising, social media and analytics partners for the same purposes. By choosing “Accept All” you agree that we store cookies on your device and process the data for the aforementioned purposes . You may revoke your consent at any time by choosing the respective settings. For more information on the processing of personal data and what specific services we use see our Privacy Policy

Privacy Preference Center

We use cookies and other technologies to collect data about your use of our site and about your browser, device and location. We process this data to help us understand how the site is used and to personalize our content and the advertising you see on this and other sites we also share this data with advertising, social media and analytics partners for the same purposes. By choosing “Accept All” you agree that we store cookies on your device and process the data for the aforementioned purposes . You may revoke your consent at any time by choosing the respective settings. For more information on the processing of personal data and what specific services we use see our Privacy Policy

Necessary Cookies

These cookies are required to provide you with our site and its functions. Since storing these cookies is necessary for the provision of our site and its functions, you cannot disable them. If you block these cookies via you browser settings our site may not function properly.

Analyse Cookies

These cookies enable us to use website analytics in order to improve our site or provide you with personalized content. They may be set by us or by third party providers whose services we have added to our pages.

Marketing Cookies

These cookies enable us to use online marketing and advertising in order to provide you on this or on other sites with personalized advertisement. They may be set by us or by third party providers whose services we have added to our pages.